1. Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils
   Alexander H Stegh, 2012, Expert Opinion on Therapeutic Targets CrossRef
2. Recent trends in cancer drug resistance reversal strategies using nanoparticles
   Srinath Palakurthi et al, 2012, Expert Opinion on Drug Delivery CrossRef
3. CHL1 Is Expressed and Functions as a Malignancy Promoter in Glioma Cells.
   Zhai Yang et al, 2017, Front Mol Neurosci CrossRef
4. null
   Meisam Akhlaghdoust et al, 2022 CrossRef
5. Targeting Options of Tumor-Associated Macrophages (TAM) Activity in Gliomas
   Filippos Anagnostakis et al, 2023, CN CrossRef